Stay updated on B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the record for the terminated FIERCE-22 study, including its study details, eligibility criteria, outcomes, locations, and documents, rather than a 403 error screen.
    Difference
    75%
    Check dated 2026-11-08T14:30:21.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:42:54.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T15:36:44.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T20:31:13.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1; the study record remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T20:44:04.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page, indicating an updated version of the study record. Several legacy study record update notes and related metadata were removed, reflecting an update to the page's history and organization.
    Difference
    18%
    Check dated 2026-09-20T19:43:32.000Z thumbnail image

Stay in the know with updates to B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.